ZIMLABNSEZim Laboratories LimitedMediumNeutral
Announced Thu, 9 Apr · 15:06 IST

Zim Laboratories Limited has informed the Exchange about Acquisition - General Updates

Listed Co AcquisitionStrategic Transactions View source PDF

ZIMLAB · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.1%1-day move
₹71.50
prior close
₹71.77
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2-0.6-0.2+1.1+1.4+6.3+7.5+12.0+18.9+31.5+54.7+58.1+62.1
Up moveDown movePending
AI summary

Zim Laboratories Limited has disclosed an investment of Rs. 89,45,100 (approximately Rs. 89.45 lakhs), equivalent to AUD 135,000, in the equity shares of ZIMTAS Pty Ltd, an Australian company. Following this investment, the company now holds 99.96% of the total share capital of ZIMTAS Pty Ltd, making it a near-wholly-owned subsidiary. This investment is part of a previously approved investment limit of up to Rs. 2.00 crores. The disclosure is made under SEBI LODR Regulation 30 and references earlier intimations from May and July 2024.

Likely market impact

This acquisition gives Zim Laboratories significant control over its Australian subsidiary, strengthening its international footprint. Shareholders may view this positively as it represents expansion using approved capital within limits.